Functional significance of erythropoietin receptor expression in breast cancer.

被引：0
作者：
Haroon, ZA
Amin, K
Karayal, AF
Cho, SC
Raleigh, JA
Varia, MA
Arcasoy, MO
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] SRI Int, In Vivo Biol, Menlo Pk, CA 94025 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1267
引用
收藏
页码：300A / 301A
页数：2
相关论文
共 50 条
[31]   Immuno-DNA assay for functional estrogen receptor in breast cancer. [J].
Nargessi, RD ;
Khabbaz, NF ;
Beard, C ;
Xu, XM ;
Shimizu, RM .
CLINICAL CHEMISTRY, 1997, 43 :531-531
[32]   Significance of epidermal growth factor receptor expression in breast cancer [J].
Badovinac-Crnjevic, Tanja ;
Jakic-Razumovic, Jasminka ;
Podolski, Paula ;
Plestina, Stjepko ;
Sarcevic, Bozena ;
Munjas, Radenka ;
Vrbanec, Damir .
MEDICAL ONCOLOGY, 2011, 28 :S121-S128
[33]   Significance of epidermal growth factor receptor expression in breast cancer [J].
Tanja Badovinac-Crnjevic ;
Jasminka Jakic-Razumovic ;
Paula Podolski ;
Stjepko Pleština ;
Božena Šarčević ;
Radenka Munjas ;
Damir Vrbanec .
Medical Oncology, 2011, 28 :121-128
[34]   Expression and Function of Erythropoietin Receptor (EpoR) Variant Forms in Human Breast Cancer [J].
Rakosy, Z. ;
Paragh, G. ;
Acs, G. .
LABORATORY INVESTIGATION, 2011, 91 :397A-397A
[35]   Prognostic significance of tartrate-resistant acid phosphatase expression in breast cancer. [J].
Dai, Ming-Shen ;
Lo, Hao-Chan ;
Chen, Li-Jia ;
Tseng, Shun-Fu .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[36]   Prognostic significance of topoisomerase II alpha (Topo II) expression in breast cancer. [J].
Depowski, PL ;
Rosenthal, SI ;
Brien, TP ;
Stylos, S ;
Johnson, RL ;
Ross, JS .
LABORATORY INVESTIGATION, 1999, 79 (01) :19A-19A
[37]   Clinical significance of LKB1 protein and gene expression in breast cancer. [J].
Chen, I. Chun ;
Chang, Yuan-Ching ;
Lu, Yen-Shen ;
Huang, Chiun-Sheng ;
Kuo, Wen-Hung ;
Wang, Ming-Yang ;
Kuo, Kuan-Ting ;
Wu, Pei-Fang ;
Hsueh, Tsu-Hsin ;
Lin, Ching-Hung ;
Cheng, Ann-Lii .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[38]   Significance of FAP, SMA and CD31 Expression in the Stroma of Breast Cancer. [J].
Tchou, J. ;
Satija, C. ;
Zhang, P. ;
Bi, Y. ;
Davuluri, R. ;
Chen, H. ;
Majumdar, R. ;
Mies, C. ;
Herlyn, M. ;
Pure, E. .
CANCER RESEARCH, 2011, 71
[39]   Expression of the androgen receptor and its association with disease outcome in breast cancer. [J].
Murphy, N. ;
Bianco-Miotto, T. ;
Ricciardelli, C. ;
Ruiz, A., I ;
Segara, D. ;
McNeil, C. M. ;
Crea, P. ;
Henshall, S. M. ;
Birrell, S. N. ;
Butler, L. M. ;
Sutherland, R. L. ;
Tilley, W. D. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 :S262-S263
[40]   Significance of chromosome 17 polysomy in breast cancer. [J].
Galamaga, Robert W. ;
Mariani, Rachel ;
Almanaseer, Imad ;
Bitran, Jacob D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345